LongevityNAD+ therapy: A benefit/risk analysis

Fred

NAD+ therapy: A benefit/risk analysis

Post by Fred »

NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis

"Most studies indicated that the NAD+ precursors NAM, NR, nicotinamide mononucleotide (NMN), and to a lesser extent NAD+ and NADH had a favourable outcome on several age-related disorders associated with the accumulation of chronic oxidative stress, inflammation and impaired mitochondrial function.

While these compounds presented with a limited acute toxicity profile, evidence is still quite limited and long-term human clinical trials are still nascent in the current literature.

Potential risks in raising NAD+ levels in various clinical disorders using NAD+ precursors include the accumulation of putative toxic metabolites, tumorigenesis and promotion of cellular senescence.

Therefore, NAD+ metabolism represents a promising target and further studies are needed to recapitulate the preclinical benefits in human clinical trials."

The authors conclude the review with: "Overall, consuming more nutritious plant foods and less meat remains the best guidelines to obtain "real‟ health benefits and improve healthspan."

https://sci-hub.se/downloads-ii/2020-01 ... 110831.pdf